BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, February 21, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Money raised by biopharma

Feb. 20, 2026
Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.
Read More

Biopharma money raised: Jan. 1-Feb. 19, 2026

Feb. 20, 2026
Year-to-date money raised in public, private and other financings of biopharma companies.
Read More

Regulatory actions for Feb. 20, 2026

Feb. 20, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Acrotech, Astrazeneca, Breath Diagnostics, Daiichi, Dror Ortho Design, GE Healthcare, Hansa, Pilatus, Regeneron, Sibel, Skylinedx.
Read More

Other news to note for Feb. 20, 2026

Feb. 20, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Angiodynamics, Briacell, Briapro, Cassava, Catheter Precision, Devonian, Johnson & Johnson, Senseonics, Sequel.
Read More

In the clinic for Feb. 20, 2026

Feb. 20, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Avidity, Merck, Myriad Generics, Traws, Viiv, Yoltech.
Read More

Financings for Feb. 20, 2026

Feb. 20, 2026
Biopharma and med-tech companies raising money in public or private financings, including: 20/20 Biolabs, Altesa, Compass, Elumn8, Envoy, Eupraxia, Medical 21, Moleculin, Oncopeptides, Resverlogix, Sift, Starget, Ten63.
Read More

Appointments and advancements for Feb. 20, 2026

Feb. 20, 2026
New hires and promotions in the biopharma and med-tech industries, including: Artiva, Ataibeckley, Fize, Integrated, Novabridge, Phio, Reacta.
Read More

In the clinic for Feb. 18, 2026

Feb. 20, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Briacell, Compass, Cyrano, Diakonos, Eli Lilly, Entrada, Helus, Ocular, Pfizer, Rallybio, Roche, Sanofi, Teva, TG.
Read More

Today's news in brief

Feb. 20, 2026

Regulatory actions for Feb. 19, 2026

Feb. 19, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Affinia, Biomerica, Hardy, Helsinn, Immunitybio, Instanosis, Johnson & Johnson, Moderna, NG, Sandoz, Shield, Spruce, Telix.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 1757 1758 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing